Biopharma financings totaled $21.38 billion through May 2025, down sharply from $62.57 billion during the same period in 2024 ...

After a long winter, the start of summer is ushering in some much-needed sunshine, warmer weather and, for a handful of ...

China has leaped from fast follower to global pioneer in drug discovery and development. We believe that Chinese companies ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

PARIS (Reuters) -French pharma group Sanofi has agreed to buy US-based Blueprint Medicines Corporation, a biopharmaceutical ...

Shares of Liminatus Pharma rose in post-market trading after the pre-clinical stage biopharmaceutical company said it regained compliance with Nasdaq listing requirements. The stock rallied 77% to $22 ...

Sionna Therapeutics shares rose after reporting positive preliminary data from its cystic fibrosis drug trial. Shares traded 5.9% higher at $16.92.

At the ASMS Conference in Baltimore, the company highlighted several new products tailored to a range of application areas, ...